News

AddToAny

Google+ Facebook Twitter Twitter

New markers for type 2 diabetes

The presence of death receptors in the blood can be used to measure the risk of developing cardiovascular diseases and type 2 diabetes.

The claim comes in a new paper published by a team from Lund University in Sweden.

The researchers found that people with known risk factors, such as high blood sugar and high blood fats, also have heightened death receptor levels.

Death receptors are activated, for example, in the case of infections when white blood cells that have combated a virus are to be removed.

It was previously known that death receptors in the blood can be measured, but not whether an elevated level was linked to increased cell death in type 2 diabetes and arteriosclerosis.

The results show that increased cell death can be linked to increased levels in the blood of three different members of the same “death receptor family” (TNFR-1, TRAILR-2 and Fas).

Increased cell death is seen in type 2 diabetes as well as arteriosclerosis.

High blood sugar and blood fats subject the body’s blood vessels and insulin-producing beta cells to stress.

Long-term stress damages the cells and can cause the death receptors on the surface of the cell to trigger a cell suicide program within the cell.

Picture credit | iStock

Related Articles

p8-13-news-pregnant-woman-istock-867369446.jpg

Blood test for pregnant women

A new blood test to check for the potentially life-threatening condition pre-eclampsia will be available to women in England.

Blood test for rare cancer proteins

A new blood test developed at the Johns Hopkins University can identify individual molecules in human blood samples with minimal detection errors. 

p8-11-news-red-blood-cells-istock-637422184.jpg

Blood cell production insights

A healthy adult makes about two million blood cells every second, and 99% of them are oxygen-carrying red blood cells. 

Blood clot discovery

Scientists have discovered new ways in which the body regulates blood clots, which could lead to the development of better treatments to help prevent and treat conditions including heart diseases, stroke and vascular dementia.

Top